Indraprastha Medical Corporation Ltd
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
- Market Cap ₹ 3,104 Cr.
- Current Price ₹ 339
- High / Low ₹ 641 / 336
- Stock P/E 16.5
- Book Value ₹ 80.8
- Dividend Yield 1.18 %
- ROCE 35.8 %
- ROE 27.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 132% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.7%
- Company has been maintaining a healthy dividend payout of 26.3%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 1000 BSE Hospitals BSE Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 714 | 755 | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,245 | 1,356 | 1,483 | 1,524 | |
| 630 | 675 | 686 | 678 | 706 | 743 | 572 | 768 | 947 | 1,050 | 1,112 | 1,215 | 1,250 | |
| Operating Profit | 85 | 80 | 79 | 74 | 82 | 87 | 41 | 120 | 152 | 195 | 245 | 267 | 274 |
| OPM % | 12% | 11% | 10% | 10% | 10% | 11% | 7% | 14% | 14% | 16% | 18% | 18% | 18% |
| 1 | 1 | -0 | -1 | -1 | -0 | -0 | -3 | 9 | 16 | 22 | 28 | 30 | |
| Interest | 8 | 7 | 8 | 9 | 7 | 6 | 3 | 3 | 4 | 4 | 6 | 6 | 6 |
| Depreciation | 28 | 35 | 31 | 31 | 30 | 33 | 33 | 35 | 39 | 40 | 44 | 44 | 45 |
| Profit before tax | 50 | 39 | 41 | 34 | 45 | 48 | 4 | 79 | 117 | 166 | 216 | 246 | 253 |
| Tax % | 34% | 37% | 36% | 38% | 36% | 9% | 46% | 26% | 26% | 25% | 26% | 25% | |
| 32 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 124 | 161 | 184 | 188 | |
| EPS in Rs | 3.54 | 2.66 | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 20.03 | 20.51 |
| Dividend Payout % | 51% | 68% | 63% | 65% | 52% | 0% | 0% | 39% | 32% | 33% | 26% | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 19% |
| 3 Years: | 11% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 132% |
| 3 Years: | 28% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 34% |
| 3 Years: | 25% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 27% |
| 3 Years: | 29% |
| Last Year: | 27% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
| Reserves | 103 | 132 | 139 | 141 | 152 | 176 | 181 | 234 | 288 | 386 | 505 | 649 |
| 50 | 52 | 67 | 66 | 21 | 4 | 3 | 5 | 2 | 34 | 33 | 37 | |
| 196 | 185 | 160 | 134 | 157 | 177 | 157 | 131 | 173 | 212 | 222 | 214 | |
| Total Liabilities | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 991 |
| 286 | 301 | 296 | 294 | 280 | 303 | 283 | 277 | 275 | 347 | 328 | 365 | |
| CWIP | 3 | 3 | 0 | 0 | 1 | 0 | 3 | 0 | 3 | 0 | 33 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 153 | 157 | 163 | 138 | 141 | 146 | 145 | 185 | 278 | 376 | 491 | 624 | |
| Total Assets | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 991 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 144 | 200 | 157 | 167 | |
| -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | -158 | -111 | -178 | |
| -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | -32 | -46 | -46 | |
| Net Cash Flow | -0 | -0 | -0 | 1 | 14 | 4 | 5 | 17 | 11 | 9 | -0 | -57 |
| Free Cash Flow | 35 | 29 | 5 | 17 | 58 | 46 | 6 | 65 | 100 | 131 | 120 | 108 |
| CFO/OP | 98% | 104% | 57% | 82% | 110% | 113% | 88% | 95% | 102% | 127% | 89% | 88% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 | 28 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 | 28 |
| Working Capital Days | -35 | -22 | -17 | -7 | -5 | -10 | -1 | -2 | -12 | -24 | -19 | -4 |
| ROCE % | 23% | 18% | 17% | 15% | 19% | 21% | 3% | 29% | 34% | 38% | 39% | 36% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue per Bed Day (ARPOB) Rs. |
|
||||||||||
| Average Length of Stay (ALOS) days |
|||||||||||
| Discharges (Inpatient Volumes) count |
|||||||||||
| Out-patients (OPD Visits) count |
|||||||||||
| Revenue per Patient Rs. |
|||||||||||
| Bed Occupancy Rate % |
|||||||||||
| Total Operational Beds beds |
|||||||||||
| International Patients Share of Revenue % |
|||||||||||
Extracted by Screener AI
Documents
Announcements
- AGM On 24Th September, 2026-Voting Results And Consolidated Report Of Srutinizer
- Proceedings Of The AGM
- Closure of Trading Window
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- We hereby submit the copies of public notice for transfer of shares to IEPF, published on 15th September,2026 in the Financial Express, all India edition …
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- We hereby submit copies of the public notice of the 38th AGM, published in the finacial express all India editions in english language and in …
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2012
from nse
Parentage[1] [2] [3]
The company was incorporated as a joint venture between Apollo Hospitals Enterprise Ltd. (AHEL) and the Government of Delhi. As of Jun 2026, AHEL holds a 22% stake, while the Delhi Government holds a 26% stake in the company. Apollo Hospitals is a leading healthcare player that owns and operates the largest hospital chain in the country. Its network spans over 78 hospitals, 7,289 pharmacies, 2,501 diagnostic centres, more than 300 clinics and over 200 telemedicine centres